CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) today announced the addition of Stephen C. McCluski to the Company’s Board of Directors. As a result of Mr. McCluski’s appointment, the number of directors on ImmunoGen’s Board is increased to seven.